GSK's NASH trial HORIZON completes; malaria and myeloma studies stay in viewNov 13Weekly roundup, 5 itemsbelantamab mafodotinGlaxoSmithKlineUpdated
GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerOct 2Weekly roundup, 11 itemscabotegravirganfeboroleUpdated